Meldonium (dihydrate)

Meldonium (MET-88) dihydrate functions as a cardioprotective agent by cpmpetetively inhibiting γ-butyrobetaine hydroxylase (BBOX) and carnitine/organic cation transporter type 2 (OCTN2) . Mildronate dihydrate exhibits IC50 values of 34-62 μM for human recombinant BBOX and an EC50 of 21 μM for human OCTN2. Meldonium dihydrate is a fatty acid oxidation inhibitor[1][2].

Product Specifications

CAS Number

[86426-17-7]

Product Name Alternative

MET-88 (dihydrate) ; Quaterin (dihydrate)

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Mitochondrial Metabolism

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Metabolic Disease; Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/meldonium-dihydrate.html

Purity

99.0

Solubility

DMSO : 4.85 mg/mL (ultrasonic; warming; adjust pH to 4 with HCl; heat to 60°C) |H2O : 100 mg/mL (ultrasonic)

Smiles

C[N+](C)(C)NCCC([O-])=O.O.O

Molecular Formula

C6H18N2O4

Molecular Weight

182.22

Precautions

H302, H315, H319, H335

References & Citations

[1]Dambrova M, et al. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity. Pharmacol Res. 2016 Nov;113 (Pt B) :771-780.|[2]Schobersberger W, et al. Story behind meldonium-from pharmacology to performance enhancement: a narrative review. Br J Sports Med. 2017 Jan;51 (1) :22-25.|[3]Daohui Wang, et al. Meldonium Ameliorates Hypoxia-Induced Lung Injury and Oxidative Stress by Regulating Platelet-Type Phosphofructokinase-Mediated Glycolysis. Front Pharmacol. 2022 Apr 5:13:863451.